ここから。どこへでも。
MagNA Pure 96システムは、分子診断ワークフローを成功させるための純度、再現性、および検査室の効率性を保証します。最大96サンプルを1時間以内に処理し、変化するニーズに合わせて検査室の生産性を向上させます。
MagNA Pure 96キットは、簡単に装填できる充填済みのすぐに使える試薬トレイで、使いやすさと安全性を確保しています。キットと消耗品はバーコード化され、MagNA Pureオンボードスキャナーで読み取られ、在庫チェック、ローディングエラー、プロセス文書化が可能です。
MagNA Pure 96 ソフトウェアには、直感的なグラフィカルユーザーインターフェースが含まれており、サンプルのローディングからランスタートまで、システムを操作するためのすべての指示を提供します。ソフトウェアはローディングエラーを検出し、適切な是正措置のための情報をユーザーに提供します。
変化するニーズに対応するために検査室の生産性を向上させながら、高性能と組み合わせた高スループットの自動化を体験してください。シームレスなデータ管理で検査室の効率を向上させ、日々の多様なスループットニーズに対応できるように容量を拡大します。
The MagNA Pure 96 System protocols are available for download from the table below (note: not available for download in the US).
Applications are very flexible, due to a diversity of software purification protocols using barcoded, prefilled trays with ready-to-use reagents.
MagNA Pure 96 kits are designed profiting from our more than ten year expertise in magnetic glass particle technology. We have streamlined the purification process to a very small number of reagents, consumables and steps.
Optimized preprogrammed purification protocols ensure routine sample handling and high quality, reproducible nucleic acid yields. Choose the appropriate purification protocol for your sample material and target nucleic acid.
| Target | Protocol name | Input sample type and sample volumes The latest version of MagNA Pure 96 protocols are available to download from the table below (not available in US) |
Elution volume | Run time*** (h:mm) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Whole blood | Plasma (citrate) | Plasma (EDTA) | Serum | Swabs | BAL* |
Sputum | CSF | Urine | Stool | Cultured cells | Fresh-frozen tissue | FFPET** | ||||
| Bacterial, fungal and viral NA | Pathogen Universal 200 1 | 200 μL | 50, 100 μL | 1:00 | ||||||||||||
| Viral NA Plasma SV 1 | 50, 100, 200 μL | 1:00 | ||||||||||||||
|
Viral NA Plasma ext lys SV
1
Protocol optimized with external lysis reagent |
350, 450 μL lysate from 100, 200 μL sample | 1:00 | ||||||||||||||
| Viral NA Universal SV 1 | 50, 100, 200 μL | 50, 100, 200 μL | 1:00 | |||||||||||||
| Pathogen Universal 500 2 | 500 μL | 1:30 | ||||||||||||||
| Pathogen Universal 1000 2 | 1000 μL | 1:40 | ||||||||||||||
| Viral NA Plasma LV 2 | 500 μL | 1:10 | ||||||||||||||
| Viral NA Plasma LV 1000 2 | 1000 μL | 1:20 | ||||||||||||||
|
Viral NA Plasma ext lys LV
2
Protocol optimized with external lysis reagent |
1000 μL lysate from 500 μL sample | 1:10 | ||||||||||||||
| Viral NA Universal LV 2 | 500 μL | 500 μL | 1:30 | |||||||||||||
| Viral NA Universal LV 1000 2 | 1000 μL | 1000 μL | 1:30 | |||||||||||||
| Genomic DNA |
DNA Blood SV
1
Recommended for elution of predominantly double-stranded DNA |
50, 100 or 200 μL ≤ 2x106 cells/samples | 50, 100 μL | 1:00 | ||||||||||||
|
DNA Blood ext lys SV
1
Protocol optimized with external lysis reagent |
300, 350, or 450 μL lysate from 50, 100, 200 μL sample |
0:50 | ||||||||||||||
| DNA Cells SV 1 | Up to 5x105 cultured cells in 200 μL PBS | 100 μL | 1:00 | |||||||||||||
| DNA Tissues SV 1 | Up to 5 mg in 200 μL | 100, 200 μL | 1:20 | |||||||||||||
| DNA FFPE SV 1 | 200 μL lysate from 2x5 μL sections | 50, 100 μL | 1:00 | |||||||||||||
| DNA Blood LV 2 | 500 μL (≤ 1x107 cells/ml) | 100, 200 μL | 1:20 | |||||||||||||
| DNA Blood LV 1000 2 | 1000 μL (≤ 1x107 cells/ml) | 1:30 | ||||||||||||||
|
DNA Blood ext lys LV
2
Protocol optimized with external lysis reagent |
1000 μL lysate from 500 μL sample (≤ 1x107 cells/ml) | 100, 200 μL | 0:50 | |||||||||||||
| DNA Cells LV 1 | Up to 1x106 cultured cells in 200 μL PBS | 100, 200 μL | 1:20 | |||||||||||||
| DNA Tissue LV 2 | Up to 25 mg in 200 μL | 200 μL | 1:20 | |||||||||||||
| Cell-free NA |
cfNA ss 2000
2
Protocol optimized for single-stranded DNA |
2000 μL | 50, 100 μL | 2:00 | ||||||||||||
|
cfNA ss 4000
2
Protocol optimized for single-stranded DNA |
4000 μL | 2:20 | ||||||||||||||
|
cfNA ds 2000
2
Protocol optimized for single-stranded DNA |
2000 μL | 100, 200 μL | 2:20 | |||||||||||||
|
cfNA ds 4000
2
Protocol optimized for single-stranded DNA |
4000 μL | 2:50 | ||||||||||||||
| Total RNA | Cellular RNA LV 3 | Up to 1x106 cultured cells in 200 μL PBS | 50, 100, 200 μL | 1:30 | ||||||||||||
| RNA Blood LV 400 3 | 900 μL stabilized whole blood from 400 μL whole blood | 50, 100, 200 μL | 1:30 | |||||||||||||
| RNA Blood LV 800 3 | 1800 μL stabilized whole blood from 800 μL whole blood | 100, 200 μL | 1:30 | |||||||||||||
| RNA PAXgene LV 3 | PAXgene pellet in 400 μL PBS | 100, 200 μL | 1:30 | |||||||||||||
| RNA PAXgene Half Tube LV 3 | Half PAXgene pellet in 200 μL PBS | 50, 100 μL | 1:30 | |||||||||||||
| RNA Tissue FF Standard LV 3 | Up to 10 mg in 350 μL | 50, 100, 200 μL | 1:30 | |||||||||||||
| RNA Tissue FF High LV 3 | Up to 25 mg in 700 μL | 100, 200 μL | 1:30 | |||||||||||||
| RNA Tissue FFPE LV 3 | 150 μL lysate from 2x5 μm sections | 50, 100 μL | 1:30 | |||||||||||||
| Liquid handling |
Sample Transfer
to the processing cartridge |
50 µL to 1000 µL | NA | |||||||||||||
|
Archive Plate Transfer
for archiving purposes |
5 μL to 200 μL | NA | ||||||||||||||
| PCR Setup with Mixing | NA | |||||||||||||||
| PCR Setup without Mixing | NA | |||||||||||||||
|
1 MagNA Pure 96 DNA and Viral NA Small Volume Kit (cat. no. 06 543 588 001) |
*BAL - Bronchoalveolar Lavage |
|||||||||||||||
